ETF Managers Group, LLC Concert Pharmaceuticals, Inc. Transaction History

ETF Managers Group, LLC

  • $2.78 Billion
  • Q1 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$3.77 - $5.24 $118,102 - $164,153
-31,327 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$4.86 - $13.07 $21,038 - $56,580
4,329 Added 16.03%
31,327 $152,000
Q4 2020

Feb 16, 2021
BUY
$9.48 - $12.84 $255,941 - $346,654
26,998 New
26,998 $342,000

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email